New Insights into Metabolic Signaling and Cell Survival: the Role of Beta-O-linkage of N-acetylglucosamine
Overview
Authors
Affiliations
The involvement of glucose in fundamental metabolic pathways represents a core element of biology. Late in the 20th century, a unique glucose-derived signal was discovered, which appeared to be involved in a variety of cellular processes, including mitosis, transcription, insulin signaling, stress responses, and potentially, Alzheimer's disease, and diabetes. By definition, this glucose-fed signaling system was a post-translational modification to proteins. However, unlike classical cotranslational N-glycosylation occurring in the endoplasmic reticulum and Golgi apparatus, this process occurs elsewhere throughout the cell in a highly dynamic fashion, similar to the quintessential post-translational modification, phosphorylation. This more recently described post-translational modification, the beta-O-linkage of N-acetylglucosamine (i.e., O-GlcNAc) to nucleocytoplasmic proteins, represents an under-investigated area of biology. This signaling system operates in all of the tissues examined and seems to have persisted throughout all multicellular eukaryotes. Thus, it comes with little surprise that O-GlcNAc signaling is an integral system and viable target for biomedical investigation. This system may be a boundless source for insight into a variety of diseases and yield numerous opportunities for drug design. This Perspective will address recent insights into O-GlcNAc signaling in the cardiovascular system as a paradigm for its involvement in other biological systems.
An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease.
Loaeza-Reyes K, Zenteno E, Moreno-Rodriguez A, Torres-Rosas R, Argueta-Figueroa L, Salinas-Marin R Front Mol Biosci. 2021; 8:751637.
PMID: 34869586 PMC: 8635159. DOI: 10.3389/fmolb.2021.751637.
Dassanayaka S, Brittian K, Long B, Higgins L, Bradley J, Audam T PLoS One. 2020; 15(11):e0242250.
PMID: 33253217 PMC: 7703924. DOI: 10.1371/journal.pone.0242250.
Liu S, Sheng H, Yu Z, Paschen W, Yang W J Cereb Blood Flow Metab. 2015; 36(2):393-8.
PMID: 26661187 PMC: 4759674. DOI: 10.1177/0271678X15608393.
High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
Dassanayaka S, Readnower R, Salabei J, Long B, Aird A, Zheng Y Biochem J. 2015; 467(1):115-26.
PMID: 25627821 PMC: 4408906. DOI: 10.1042/BJ20141018.
Protein O-GlcNAcylation and cardiovascular (patho)physiology.
Marsh S, Collins H, Chatham J J Biol Chem. 2014; 289(50):34449-56.
PMID: 25336635 PMC: 4263852. DOI: 10.1074/jbc.R114.585984.